A Piece Of The Puzzle Missing From BRF S.A.'s (BVMF:BRFS3) Share Price
BRF S.A.'s (BVMF:BRFS3) price-to-sales (or "P/S") ratio of 0.4x may look like a pretty appealing investment opportunity when you consider close to half the companies in the Food industry in Brazil have P/S ratios greater than 1x. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.
See our latest analysis for BRF
How Has BRF Performed Recently?
Recent revenue growth for BRF has been in line with the industry. It might be that many expect the mediocre revenue performance to degrade, which has repressed the P/S ratio. If you like the company, you'd be hoping this isn't the case so that you could pick up some stock while it's out of favour.
Want the full picture on analyst estimates for the company? Then our free report on BRF will help you uncover what's on the horizon.Is There Any Revenue Growth Forecasted For BRF?
BRF's P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.
Taking a look back first, we see that there was hardly any revenue growth to speak of for the company over the past year. However, a few strong years before that means that it was still able to grow revenue by an impressive 45% in total over the last three years. So while the company has done a solid job in the past, it's somewhat concerning to see revenue growth decline as much as it has.
Looking ahead now, revenue is anticipated to climb by 4.8% each year during the coming three years according to the eleven analysts following the company. With the industry predicted to deliver 3.6% growth each year, the company is positioned for a comparable revenue result.
With this information, we find it odd that BRF is trading at a P/S lower than the industry. It may be that most investors are not convinced the company can achieve future growth expectations.
What We Can Learn From BRF's P/S?
While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.
It looks to us like the P/S figures for BRF remain low despite growth that is expected to be in line with other companies in the industry. When we see middle-of-the-road revenue growth like this, we assume it must be the potential risks that are what is placing pressure on the P/S ratio. It appears some are indeed anticipating revenue instability, because these conditions should normally provide more support to the share price.
Don't forget that there may be other risks. For instance, we've identified 2 warning signs for BRF that you should be aware of.
If you're unsure about the strength of BRF's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
Valuation is complex, but we're here to simplify it.
Discover if BRF might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:BRFS3
BRF
BRF S.A. raises, produces, and slaughters poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and other products.
Excellent balance sheet and slightly overvalued.